Literature DB >> 9837956

Genomic organization and regulation of expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) gene.

M Nagase1, J Abe, K Takahashi, J Ando, S Hirose, T Fujita.   

Abstract

Lectin-like oxidized low-density lipoprotein receptor (LOX-1) is a recently identified receptor for oxidized low-density lipoprotein, one of the major atherogenic substances. Although LOX-1 was reported to be expressed abundantly in endothelial cells, including atheromatous lesions, the regulation of LOX-1 gene has not yet been clarified. In the present study, we isolated the rat LOX-1 gene and investigated the regulation of gene expression. The rat LOX-1 gene was encoded by a single copy gene spanning over 19 kilobases and consisted of eight exons. Exon boundaries correlated well with the functional domain boundaries of the receptor protein. The promoter region contained putative TATA and CAAT boxes and multiple cis-elements such as NF-kappaB, AP-1 and AP-2 sites, and a shear stress response element. Northern blot analysis revealed that LOX-1 gene expression was up-regulated 9-fold by shear stress, 21-fold by lipopolysaccharide, and 4-fold by tumor necrosis factor-alpha, in cultured vascular endothelial cells. LOX-1 was also expressed in macrophages but not in vascular smooth muscle cells. These data provide important information for elucidating the molecular mechanisms of LOX-1 gene regulation and suggest a role for LOX-1 in the pathophysiology of atherosclerotic cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9837956     DOI: 10.1074/jbc.273.50.33702

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Complex inheritance of the 5-lipoxygenase locus influencing atherosclerosis in mice.

Authors:  Anatole Ghazalpour; Xuping Wang; Aldons J Lusis; Margarete Mehrabian
Journal:  Genetics       Date:  2006-04-19       Impact factor: 4.562

2.  Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse model.

Authors:  C L Welch; S Bretschger; N Latib; M Bezouevski; Y Guo; N Pleskac; C P Liang; C Barlow; H Dansky; J L Breslow; A R Tall
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

Review 3.  New scavenger receptors and their functions in atherogenesis.

Authors:  Noriaki Kume; Toru Kita
Journal:  Curr Atheroscler Rep       Date:  2002-07       Impact factor: 5.113

4.  Autoantibodies and thrombophilia in RA: TNFalpha and TNFalpha blockers.

Authors:  G F Ferraccioli; E Gremese
Journal:  Ann Rheum Dis       Date:  2004-03-17       Impact factor: 19.103

5.  Minocycline ameliorates LPS-induced inflammation in human monocytes by novel mechanisms including LOX-1, Nur77 and LITAF inhibition.

Authors:  Tao Pang; Juan Wang; Julius Benicky; Juan M Saavedra
Journal:  Biochim Biophys Acta       Date:  2012-01-27

6.  A platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1.

Authors:  M Kakutani; T Masaki; T Sawamura
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

7.  Lipopolysaccharide augments the uptake of oxidized LDL by up-regulating lectin-like oxidized LDL receptor-1 in macrophages.

Authors:  Ekhtear Hossain; Akinobu Ota; Sivasundaram Karnan; Miyuki Takahashi; Shahnewaj B Mannan; Hiroyuki Konishi; Yoshitaka Hosokawa
Journal:  Mol Cell Biochem       Date:  2014-10-28       Impact factor: 3.396

8.  Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) transcriptional regulation by Oct-1 in human endothelial cells: implications for atherosclerosis.

Authors:  Jiawei Chen; Yong Liu; Hongmei Liu; Paul L Hermonat; Jawahar L Mehta
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

9.  Lectin-like oxidized LDL receptor-1 is a cell-adhesion molecule involved in endotoxin-induced inflammation.

Authors:  Megumi Honjo; Kayo Nakamura; Kenji Yamashiro; Junichi Kiryu; Hidenobu Tanihara; Leslie M McEvoy; Yoshihito Honda; Eugene C Butcher; Tomoh Masaki; Tatsuya Sawamura
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

10.  Candesartan reduces the innate immune response to lipopolysaccharide in human monocytes.

Authors:  Ignacio M Larrayoz; Tao Pang; Julius Benicky; Jaroslav Pavel; Enrique Sánchez-Lemus; Juan M Saavedra
Journal:  J Hypertens       Date:  2009-12       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.